Sivia Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Hold
585
0.03% 512
2026
Q1
$206K Sell
585
-627
-52% -$224K 0.04% 431
2025
Q4
$397K Sell
1,212
-6
-0.5% -$1.9K 0.08% 329
2025
Q3
$344K Buy
1,218
+32
+3% +$9.28K 0.1% 272
2025
Q2
$331K Buy
1,186
+114
+11% +$32.3K 0.11% 245
2025
Q1
$334K Buy
1,072
+46
+4% +$13.6K 0.16% 135
2024
Q4
$267K Sell
1,026
-295
-22% -$87.5K 0.13% 131
2024
Q3
$426K Buy
1,321
+87
+7% +$28.5K 0.25% 68
2024
Q2
$385K Buy
1,234
+176
+17% +$51.7K 0.26% 68
2024
Q1
$301K Sell
1,058
-5
-0.5% -$1.46K 0.2% 110
2023
Q4
$306K Buy
+1,063
New +$290K 0.23% 88

Other funds holding AMGN

Sivia Capital Partners's AMGN Position: Q2 2026 in Review

Sivia Capital Partners held its Amgen (AMGN) position steady in Q2 2026 at 585 shares worth $212K. The position accounts for 0.03% of the portfolio, ranked #512.

Sivia Capital Partners first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $426K in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sivia Capital Partners held 585 shares of Amgen worth $212K as of Q2 2026.
  • Sivia Capital Partners left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.03% of Sivia Capital Partners's portfolio in Q2 2026, its #512 holding.
  • Sivia Capital Partners first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • Sivia Capital Partners's Amgen position peaked at $426K in Q3 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sivia Capital Partners's 13F filing for Q2 2026, filed 23 Jul 2026.